Similar articles

• Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.

  Curcio F, Villano G, Masucci S, Plenzik M, Veneruso C, De Rosa G. Curcio F, et al. J Addict Med. 2011 Mar;5(1):43-9. doi: 10.1097/ADM.0b013e3181d131e0. J Addict Med. 2011. PMID: 21769046
• Commentary on Bruneau et al. (2012): injection of prescription opioid pain relievers and infectious disease risk.

  Hadland SE, Wood E. Hadland SE, et al. Addiction. 2012 Jul;107(7):1328-9. doi: 10.1111/j.1360-0443.2012.03885.x. Addiction. 2012. PMID: 22672378 No abstract available.
• Relapse to opioid use after treatment of chronic hepatitis C with pegylated interferon and ribavirin.

  Matthews AM, Fireman M, Zucker B, Sobel M, Hauser P. Matthews AM, et al. Am J Psychiatry. 2006 Aug;163(8):1342-7; quiz 1479. doi: 10.1176/ajp.2006.163.8.1342. Am J Psychiatry. 2006. PMID: 16877644 No abstract available.
• New Face of Hepatitis C.

  Wu T, Konyn PG, Cattaneo AW, Saab S. Wu T, et al. Dig Dis Sci. 2019 Jul;64(7):1782-1788. doi: 10.1007/s10620-019-05511-y. Epub 2019 Feb 13. Dig Dis Sci. 2019. PMID: 30756208 Review.
• [Hepatitis C during pregnancy, vertical transmission and new treatment possibilities].

  Muñoz-Gámez JA, Salmerón J, Ruiz-Extremera Á. Muñoz-Gámez JA, et al. Med Clin (Barc). 2016 Dec 2;147(11):499-505. doi: 10.1016/j.medcli.2016.04.003. Epub 2016 May 18. Med Clin (Barc). 2016. PMID: 27209226 Review. Spanish.